Today: 30 April 2026
GE Vernova (GEV) stock jumps as GLJ lifts target to $1,087; Baird turns cautious on competition
12 January 2026
1 min read

GE Vernova (GEV) stock jumps as GLJ lifts target to $1,087; Baird turns cautious on competition

New York, Jan 12, 2026, 12:29 EST — Regular session

  • Shares of GE Vernova rose in midday trading after new analyst targets were published.
  • GLJ Research issued the highest target on the Street, while Baird downgraded its rating to Hold.
  • All eyes turn to the Jan. 28 results, the next key catalyst for investors.

Shares of GE Vernova Inc. climbed Monday after GLJ Research raised its price target to $1,087 from $805. Meanwhile, Baird downgraded the stock to Hold, cutting its target to $649. The stock was up 2.7% at $639.38 by midday, fluctuating between $614.33 and $644.73 earlier. Baird cited increasing competition from Doosan, Boom Technology, FTAI Aviation, and Caterpillar.

The tug-of-war is critical now since investors view GE Vernova stock as a stand-in for limited power equipment—gas turbines, grid gear, and the ongoing service contracts. Data centers loom behind much of this demand, pushing the market to price the company as if supply constraints will persist.

The stock has become volatile amid fresh claims on pricing and capacity. As earnings near, traders are weighing if service margins will continue to beat expectations or if the supply narrative will subtly shift.

GLJ raised its target after factoring in quicker price hikes at GE Vernova’s Power Services unit. The firm now projects 2028 EBITDA at $13.8 billion, well above both the Street’s $10.8 billion estimate and the company’s own $10.4 billion target; EBITDA refers to earnings before interest, taxes, depreciation, and amortization. That said, GLJ noted “limited positive catalysts and negative rate of change for data center headline risk” in the near term. Investing.com

Baird’s downgrade focused on a different angle: what if the turbine market moves from shortage to a more balanced state? In that case, prices for new equipment could ease up even if demand remains strong, creating a tricky situation for valuations.

Back in December, GE Vernova laid out an optimistic forecast for 2026 and boosted its share buyback plan by $4 billion. Analysts at RBC Capital Markets noted at the time: “The outlook leaves room for further outperformance,” highlighting anticipated growth in its power and electrification divisions. Reuters

The company separated from General Electric in April 2024, with GE Aerospace becoming an independent entity.

GE Vernova will release its fourth-quarter and full-year 2025 results on Jan. 28, ahead of the market open. CEO Scott Strazik and CFO Ken Parks are set to review the figures during a 7:30 a.m. ET webcast, the company announced.

That upside scenario hinges on pricing holding firm and execution running smoothly. If data center expansion slows, utilities cut back spending, or competitors ramp up output quicker than expected, new equipment prices could come under pressure, weighing on the services growth that bulls count on.

The next big date is Jan. 28, when the report drops. Investors want to see if there’s a shift in 2026 growth and cash-flow goals, along with clues about turbine capacity. Those details will probably overshadow the fresh batch of price targets.

Stock Market Today

  • Tempus AI (TEM) Stock Rises 10.6% After Recent Slump, Valuation Insights
    April 30, 2026, 2:06 PM EDT. Tempus AI (TEM) shares gained 10.61% over the last month, contrasting with a 16.38% fall in three months and a 19.79% drop year to date. The stock currently trades at $50.02, below Simply Wall St's fair value estimate of $72.40, indicating a possible undervaluation of about 30.9%. A discounted cash flow (DCF) model places intrinsic value even higher, near $102.50, suggesting potential upside or optimistic forecasts. Tempus AI's growth prospects hinge on rising clinical-genomic testing volumes, biopharma partnerships, and AI adoption in healthcare. Risks include slow reimbursement for new assays and possible cuts in pharma data budgets. Investors should weigh these factors carefully amid mixed signals from recent price movements and valuation metrics.

Latest article

Carvana Stock Fell Even After Record Sales. The Margin Catch Is Why

Carvana Stock Fell Even After Record Sales. The Margin Catch Is Why

30 April 2026
Carvana shares fell 1.8% to $389.39 Thursday afternoon after the company reported record first-quarter sales and profit but a decline in gross profit per vehicle. Carvana sold 187,393 retail vehicles, up 40%, with revenue rising 52% to $6.43 billion and net income reaching $405 million. Gross profit per retail unit dropped to $6,783 from $6,938 a year earlier. Wall Street analysts raised price targets despite margin pressure.
Cigna’s Obamacare Exit Puts 369,000 Members on the Clock for 2027 Coverage

Cigna’s Obamacare Exit Puts 369,000 Members on the Clock for 2027 Coverage

30 April 2026
Cigna Group will exit the Affordable Care Act individual insurance market after 2026, affecting about 369,000 members in 11 states who must find new coverage for 2027. The announcement came as Cigna reported first-quarter revenue of $68.5 billion and raised its 2026 earnings outlook. CVS Health’s Aetna previously withdrew from the ACA market for 2026, impacting about 1 million enrollees.
Nvidia stock gains on Eli Lilly $1 billion AI lab plan as traders eye TSMC, earnings
Previous Story

Nvidia stock gains on Eli Lilly $1 billion AI lab plan as traders eye TSMC, earnings

Harmony Gold stock jumps nearly 10% as gold cracks $4,600; CPI looms for HMY
Next Story

Harmony Gold stock jumps nearly 10% as gold cracks $4,600; CPI looms for HMY

Go toTop